GulfPCR-GIM 2014 announcement

December 04, 2014

Welcoming physicians from throughout the Middle East and around the world, the 2014 edition of GulfPCR-GIM will take place at the Grand Hyatt in Dubai, United Arab Emirates, from December 11th to 12th. Dedicated to improving cardiovascular care in the Middle East and surrounding regions, this highly interactive Course offers an international platform for sharing the experience and traditions of all participants. Growing out of the 2011 association of two dynamic groups - PCR, one of the foremost organisations for medical education today, and GIM, the Gulf Interventional Meeting - GulfPCR-GIM brings together PCR and GIM's long-standing commitment to exchange, education and evolution in the clinical technologies and techniques used in interventional cardiovascular medicine today.

Led by Course Directors Ibrahim Al Rashdan from Kuwait, Haitham Amin from Bahrain, Andreas Baumbach from the United Kingdom and Jean Fajadet from France, GulfPCR-GIM has quickly become a pre-eminent forum in the region offering its participants the chance to experience the cutting edge in cardiovascular and interventional medicine.

The 2014 edition of GulfPCR-GIM will have several new features, including, for the first time, "Live" case transmissions from the King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia. There will be a special programme this year on "How to start a peripheral programme", addressing a growing demand from interventional cardiologists required to treat peripheral artery disease, a serious medical challenge often related to patients suffering from cardiovascular disease. More details on these new features as well as all the many topics covered during the Course can be found on the Course website.

Firmly rooted in the tradition of medicine and science in the Middle East, GulfPCR-GIM is a meticulously designed forum, facilitating the exchange and expression of knowledge and experience for committed healthcare professionals from the Gulf, Middle East, Turkey, North Africa...and the world.
-end-


PCR

Related Cardiovascular Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Meditation linked to lower cardiovascular risk
Meditation was linked to lower cardiovascular risk in a large database study by Veterans Affairs researchers and colleagues.

Framework on how to safely resume essential cardiovascular diagnostic and treatment care during the COVID-19 pandemic, from the AHA and 14 North American cardiovascular societies
The American Heart Association, together with 14 cardiovascular societies in North America, today issued joint guidance, 'Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership,' to outline a systematic, phased approach to safely reintroducing cardiovascular procedures for diagnosis and treatment during the COVID-19 pandemic.

Cardiovascular impairment in COVID-19
Anti-inflammatory therapies should be used to treat COVID-19 patients that are at risk of, or have developed, cardiovascular problems, recommend leading cardiologists from Beijing, China, who have detailed the different ways that COVID-19 could trigger serious inflammatory-related cardiovascular issues in patients.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Improving cardiovascular health of the most vulnerable
A two-year pilot project led by Rick Stouffer, MD, shows how the cardiovascular health of the most vulnerable patients can be improved with free medications.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Aspirin may no longer be effective as cardiovascular treatment
A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Vitamin D supplementation not associated with reduced cardiovascular events
This study, called a meta-analysis, combined the results of 21 randomized clinical trials with about 83,000 patients to look at whether vitamin D supplementation was associated with reduced risk of cardiovascular disease events such as heart attack or stroke.

Read More: Cardiovascular News and Cardiovascular Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.